Pharmaceuticals

Advanced Empty Capsule Market Size, Share & Trends Analysis Report By Product (Oral Capsules, Inhalation Capsules), By Raw Material (Animal Source, Vegetarian Based), By Capsule Size, By End-User, By Region, And By Segment Forecasts, 2025-2034

Advanced Empty Capsule Market Size is valued at USD 1.9 Billion in 2024 and is predicted to reach USD 5.1 Billion by the year 2034 at a 10.6% CAGR during the forecast period for 2025-2034.   Advanced Empty Capsules are used to deliver various kinds of drugs without altering their formulation. These capsules are designed so that they do not interfere with any drug formulation and ensure proper drug delivery. Growing incidence of chronic dis...

Report ID: 1233  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 185

mRNA Extraction and Purification Market Size, Share & Trends Analysis Report By Product (Kits/Reagents, Instruments), By Application(Infectious Disease Vaccines, Other Vaccines, Therapeutics and Others), By End-User, By Region, And Segment Forecasts, 2025-2034

Global mRNA Extraction and Purification Market Size is valued at USD 1105.2 Million in 2024 and is predicted to reach USD 7561.2 Million by the year 2034 at a 21.6% CAGR during the forecast period for 2025-2034. Purification and isolation or extraction processes are mandatory for all types of medical research. mRNA Purification and extraction are performed by using different kinds of methods. Many specialized methods are av...

Report ID: 1285  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 190

GLP-1 Market Size, Share & Trends Analysis Report By Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist, Short-acting GLP-1 Agonist), By Type of Agonist (Single Agonist, Dual Agonist, Tri-agonist), By Molecule Type (Biologic Peptide GLP-1 Agonists, Small-Molecule Non-Peptide GLP-1 Agonists), By Active Compound (Semaglutide, Tirzepatide, Dulaglutide, Liraglutide, Lixisenatide, Exenatide, Orforglipron, Retatrutide, Survodutide, Other Active Compounds), By Route of Administration (Oral, Parenteral), By Dosing Frequency (Daily, Weekly, Monthly or Extended-Interval), By Delivery System, By Target Indication, By Payer, By Region and By Segments Forecasts, 2025-2034

Global GLP-1 Market Size is valued at USD 50.0 Bn in 2024 and is predicted to reach USD 141.9 Bn by the year 2034 at an 11.1% CAGR during the forecast period for 2025-2034. The glucagon-like peptide-1 receptor (GLP1R) is a crucial target in treating type 2 diabetes and obesity, given its significant role in regulating blood sugar levels and appetite. GLP-1, a hormone produced in the gut, enhances insulin secretion from pancreatic beta cells in r...

Report ID: 2592  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Patient Support Programs (PSP) Market Size, Share & Trends Analysis Report By Functionality (Communication, Health Tracking & Insights, Billing & Payments, Administrative, Patient Education, Others), By Therapeutic area (Health & Wellness, Chronic Disease Management, Others), By Application, By End-user, By Region, And By Segment Forecasts, 2025-2034

Global Patient Support Programs (PSP) Market Size is valued at USD 21.8 Billion in 2024 and is predicted to reach USD 104.7 Billion by the year 2034  at a 17.1% CAGR during the forecast period for 2025-2034. The patient support programs (PSP) market is a rapidly expanding segment of the healthcare and pharmaceutical industries, driven by an increased emphasis on patient-centric care and the desire to improve treatment outcomes. PSPs are i...

Report ID: 2197  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 179

High Potency Drug Market Size, Share & Trends Analysis Report By Product Type (Innovative And Generic), Dosage Form (Injectables, Oral Solids, Creams), Manufacturer Type (In-House And Outsourced). Therapeutic Area (Oncology, Hormonal Imbalance, Neurology), By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

High Potency Drug Market Size is valued at USD 185.51 Bn in 2024 and is predicted to reach USD 520.73 Bn by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Drugs classified as high potency are those whose active ingredient is highly concentrated or potent and is designed to produce therapeutic effects at low dosages. Dosage forms for high-potency drugs include tablets, capsules, and liquid formulatio...

Report ID: 2505  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Pharmaceutical Contract Sales Outsourcing [CSO] Market Size, Share & Trends Analysis Report By Service (Personal Promotion (Promotional Sales Team (Dedicated Sales Team, Syndicated Sales Team), Key Account Management, Vacancy Management), Non-personal Promotion, Others), By Therapeutic Area, By Region, And by Segment Forecasts, 2025-2034

Pharmaceutical Contract Sales Outsourcing [CSO] Market Size is valued at USD 10.80 Bn in 2024 and is predicted to reach USD 25.80 Bn by the year 2034 at a 9.2% CAGR during the forecast period for 2025-2034.   Pharmaceutical Contract Sales Outsourcing (CSO) refers to the practice of pharmaceutical companies partnering with external organizations to handle various aspects of their sales and marketing efforts. Due to cost reductions...

Report ID: 2063  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Psychedelic Therapeutics Market Size, Share & Trends Analysis Report, by Origin of Substance (Natural and Synthetic), Type of Psychedelic Substance (Gamma-hydroxybutyrate, Ketamine, MDMA, and Psilocybin), Target Disease Indications (Depression and Anxiety Disorders, Pain Disorders, Sleep Related Disorders and Trauma), Route of Administration, By Region, Forecasts, 2025-2034

Psychedelic Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.6 Billion by the year 2034 at a 15.6 % CAGR during the forecast period for 2025-2034. Psychedelic medicines are also referred to as hallucinogenic. Psychedelic medicines are a group of substances, including chemicals, such as LSD, and plants used to treat multiple mental disorders, including resistant depression, opiate addiction, and pani...

Report ID: 1329  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 190

Mental Wellness Market Size, Share & Trends Analysis Report By Disorder, By Type, By Age Group (Adults, Geriatric, Teenager), By Distribution Platform, By Region, And By Segment Forecasts, 2025-2034

Global Mental Wellness Market Size is valued at USD 159.0 Billion in 2024 and is predicted to reach USD 355.4 Billion by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increased smartphone adoption and mHealth therapies are driving the mental wellness market.  Growing Awareness of Stress Management is driving the mental wellness market. North America domin...

Report ID: 1330  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Biopharmaceutical Fermentation Market Size, Share & Trends Analysis Report By Product Type (Upstream Process, Downstream Products), By Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, Others), By End-Use, By Region, And By Segment Forecasts, 2025-2034

Global Biopharmaceutical Fermentation Market Size is valued at 10.5 Billion in 2024 and is predicted to reach 19.6 Billion by the year 2034 at an 6.6 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing emphasis of companies on creating innovative biological drugs is projected to drive the need for fermentation services and products, contributing to market growth. However, adhe...

Report ID: 1410  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 180

Rare Kidney Diseases Market Size, Share & Trends Analysis Report By Target Indication, By Type of Molecule (Small Molecules, Biologics, By Route of administration (Oral, Intravenous, Subcutaneous, Others), By End-User, By Distribution, By Region, And By Segment Forecasts, 2025-2034

Global Rare Kidney Diseases Market Size is valued at USD 2.9 Billion in 2024 and is predicted to reach USD 8.1 Billion by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The emergence of the rare kidney disease market is credited to the improved understanding and identification of these conditions, resulting in higher diagnosis rates. The increasing incidences an...

Report ID: 1414  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 190